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ABSTRACT 
The incidence of methicillin-resistant Staphylococcus 
aureus (MRSA) in hospitalized patients and 
apparently healthy individuals was investigated in 
two western states of Nigeria using standard 
microbiological methods. One thousand and two 
hundred non-repeat isolates of S. aureus were 
recovered from the subjects. At varying degrees the 
isolates were resistant to cotrimoxazole (54.8%), 
augmentin (36.9%), pefloxacin (35.9%), gentamycin 
(28.3%), erythromycin (24.9%), vancomycin (10.3%), 
ofloxacin (5.2%) and ciprofloxacin (0.3%). One 
hundred and fifty six (13.0%) were resistant to 
methicillin out of which 4.8% and 8.2% were from 
healthy individuals and patients respectively. There 
was no correlation between prevalence of MRSA and 
age or sex (p < 0.05). There was no correlation 
between the antibiotic resistance pattern in MRSA 
from healthy volunteers and patients (P < 0.05). A 
total of 9.0%, 12.2% and 21.2% of the MRSA were 
resistant to 3, 4 and 5 antibiotics respectively. 
Antibacterial activities of five biocides examined 
using agar diffusion method showed that 38.5%, 
53.2%, 59.6%, 61.5% and 71.8% of the MRSA were 
not inhibited by Izal®, Morigad®, Septol®, Dettol® and 
Purit® respectively, at concentrations two times 
higher than the in-use concentration.  This finding 
points to the fact that MRSA occurs among patients 
and in the communities in the study areas, which 
calls for a public health concern and awareness. 
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INTRODUCTION  
taphylococcus aureus is an opportunistic 
pathogen causing diseases and infections in 
both man and animal. It causes wide varieties 
of acute suppurative infections which include 
superficial, subcutaneous, sub-mucous 
infections47,13,38,2,32,50 characterized by 
inflammation, necroses, and abscess 
formation5,7,31.  
Staphylococcus aureus is an extremely versatile 
and frequent pathogen of humans both in the 
community and in the hospitals10,35,7,37. Despite 
standardized hygienic measures, the high rate of 
tolerance, adaptation to new environments and 
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increasing resistance to antibiotics are the major 
factors responsible for the recent upsurge in the 
rate of staphylococcal infections27,10,50.  
The acquisition of mecA gene by S. aureus has been 
confirmed to be responsible for its methicillin 
resistance29. Methicillin-resistant S. aureus (MRSA) 
was first isolated in  England and was initially 
considered a nosocomial pathogen, however in 
recent years, increasing numbers of MRSA strains 
have been isolated worldwide from patients with 
community-acquired infections45,42,43,21,6.  
Staphylococcus aureus represents a major public 
health threat, as MRSA strains are the leading 
cause of nosocomially acquired infections. MRSA 
infections present a challenge to infection control 
and treatment strategies, resulting in increased 
morbidity, mortality, and length of hospitalization 
and health care costs44,28,6,38. 
Kesah et al.26 reported 21–30% MRSA in 8 African 
countries including Nigeria. Shittu et al.48 also 
reported emergence of a variant of epidemic strain 
MRSA in South Western Nigeria. However, this 
study was aimed at isolating and determining of 
methicillin resistance among S. aureus strains from 
Ekiti and Ondo States, Nigeria. 
 
MATERIALS AND METHODS 
COLLECTION AND PROCESSING OF SAMPLES 
One thousand and two hundred non-repeat 
samples of Staphylococcus aureus from various 
clinical specimens and apparently healthy 
volunteers were collected in Ekiti and Ondo States 
of Nigeria. Informed consent was obtained from all 
patients before the samples were collected and all 
experiments were performed in accordance with 
the international ethical standards. Samples were 
inoculated on Mannitol Salt Agar (MSA) and 
incubated at 35°C for 24 h. Colonies with brilliant 
yellow appearance were sub-cultured to get pure 
isolates. Pure isolates were identified by standard 
methods described by Olutiola et al.39 and Fawole 
and Oso18 while the results were interpreted 
according to Holts and collegues23. 
 
ANTIBIOTIC SENSITIVITY TESTING 
The isolates were grown at 37 °C in Mueller-Hilton 
broth (Oxoid) for 18 h and diluted to an optical 
density of 0.1 (0.5 McFarland Standard) and stored 
at 4 °C. The disc diffusion method was used for 
susceptibility testing as described by Clinical and 
Laboratory Standard Institute, CLSI12. The isolates 
were tested against the following commercial 
antibiotic with their concentrations (µg): 
amoxicillin (25), augmentin (30), ciprofloxacin 
(10), cotrimoxazole (25), erythromycin (5), 
gentamicin (10), ofloxacin (30), oxacillin (5), 
perfloxacin (5), and vancomycin (5). Oxford 
Staphylococcus aureus (NCTC 6571) was used as 
control strain. Multiple antibiotic resistance was 
determined for strains that are not susceptible to 
oxacillin, which is taken for methicillin resistance 
according to Onemu and Ophori40. Agar dilution 
method was used to determine susceptibility of 
isolates to commonly used biocides. 
 
STATISTICAL ANALYSIS OF DATA 
Statistical analysis was done using SPSS (version 
17) to determine frequency distribution, mean, 
harmonic mean, standard deviation, analysis of 
variance (ANOVA), Duncan Multiple Range and 
Pearson correlation coefficient. 
 
RESULTS 
The distribution of the S. aureus strains recovered 
from subjects is represented in Table 1.  A total of 
498 (41.5%) and 702 (56.5%) was recovered from 
both male and female subjects respectively. The 
antibiotic susceptibility test of 1,200 S. aureus is 
shown in Table 2. . One hundred and fifty-six 
(13.0%) were resistant to methicillin antibiotic.  
 
Table 1. The distribution of S. aureus recovered from the study areas. 
State Healthy (%) Patients (%) Total 
Male Female Male Female Male  Female  
Ekiti 154 (12.8) 284 (23.7) 114 (9.5) 48 (4.0) 268 (22.3) 332 (27.7) 
Ondo 191 (15.9) 308 (25.7) 39 (3.3) 62 (5.2) 230 (19.2) 370 (30.8) 
Total 345 (28.8) 592 (49.3) 153 (12.8) 110 (9.2) 498 (41.5) 702 (58.5) 
 
Antibiotic susceptibility test showed that most of 
the MRSA isolates were resistant to all the 
antibiotics tested in varying degrees. Resistance to 
cotrimoxazole was highest (87.2%) whereas it was 
least against ciprofloxacin (1.3%). This was 
followed by ofloxacin (37.2% resistance) and 
pefloxacin (46.8% resistance). One hundred and 
thirty six (87.2%) strains being highest were 
resistant to cotrimoxazole, 130 (83.3%) to 
amoxicillin and 118 (75.6%) to vancomycin. There 
was no statistically significant difference between 
the antibiotic resistance pattern in MRSA from 
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Table 2. Distribution of Staphylococcus aureus according to antibiotics susceptibility testing. 
Antibiotic Ekiti (n = 600) Ondo (n = 600) 
Healthy (%) Patients (%) Healthy (%) Patients (%) 
R S R S R S R S 
Aug 159(13.3) 279 (23.3) 91 (7.6) 71 (5.9) 113 (9.4) 386 (32.2) 80 (6.7) 21 (1.8) 
Amox 78 (6.5) 360 (30.0) 57 (4.8) 105 (8.8) 50 (4.2) 449 (37.4) 44 (3.7) 57 (4.8) 
Cip 1 (0.08) 437 (36.4) 1 (0.08) 161 (13.4) 1 (0.08) 498 (41.5) 0 (0) 101 (8.4) 
Cotr 211 (17.6) 227 (18.9) 109 (9.1) 53 (4.4) 251 (20.9) 248 (20.7) 87 (7.3) 14 (1.2) 
Ery 91 (7.6) 347 (28.9) 53 (4.4) 109 (9.1) 84 (7.0) 415 (34.6) 71 (5.9) 30 (2.5) 
Gen  125 (10.4) 313 (26.1) 97 (8.1) 65 (5.4) 83 (6.9) 416 (34.7) 35 (2.9) 66 (5.5) 
Oflo 30 (2.5) 408 (3.4) 24 (2.0) 138 (11.5) 7 (0.6) 492 (41.0) 1 (0.08) 100 (8.3) 
Oxa 9 (0.8) 429 (35.8) 51 (4.3) 111 (9.3) 49 (4.1) 450 (37.5) 47 (3.9) 54 (4.5) 
Pef 202 (16.8) 236 (19.7) 67 (5.6) 95 (7.9) 118 (9.8) 381 (31.8) 44 (3.7) 57 (4.8) 
Van  8 (0.7) 430 (35.8) 33 (2.81) 129 (10.8) 42 (3.5) 457 (38.1) 41 (3.4) 60 (5.0) 
AMX=amoxicillin, AUG=augmentin, CIP=ciprofloxacin, COT=cotrimoxazole, ERY=erythromycin, GEN=gentamicin, 
OFL=ofloxacin, OXA=oxacillin, PEF=perfloxacin, VAN=vancomycin, S=Susceptible, R=resistance 
 
Multiple antibiotic resistance (MAR) of MRSA 
strains was investigated. All the organisms showed 
multiple resistance in varying degrees ranging. 
Forty two (26.9%), 28 (18.0%) and 6 (3.9%) were 
resistant to 6, 7 and 8 antibiotics among the MRSA 
strains respectively. None was resistant to all the 9 
antibiotics tested (Table 3). 
 
Table 3. Multiple Antibiotic Resistance (MAR) Strain among MRSA strains. 
Number of Antibiotic MRSA strain Percentage 
3 14 9.0 
4 19 12.2 
5 33 21.2 
6 42 26.9 
7 28 18.0 
8 6 3.9 
 
Most of the MRSA isolates tested against the 
various concentrations/dilutions of the commonly 
used disinfectants were resistant. Overall, 156 
(100.0%) strains of MRSA from both Ekiti and 
Ondo States were resistant to all the disinfectants 
at the concentrations lower than the in-use 
concentrations recommended by manufacturers. 
At the recommended concentrations, 109 (69.9%) 
strains of MRSA from Ekiti and Ondo states were 
resistant to Izal® whereas 145 (92.9%), 145 
(92.9%), 144 (92.3%) and 140 (89.7%) were 
resistant to Septol®, Dettol®, Purit® and Morigad® 
respectively.  
At concentrations above the recommended in-use 
concentrations, the antimicrobial activity of the 
disinfectants revealed that 91 (58.3%) MRSA 
strains from or from Ekiti and Ondo were resistant 
to Izal®while 109 (69.9%), 126 (80.0%) and 130 
(83.3%) resistant to Morigad®, Dettol® and Purit® 
respectively. Septol® was the least effective among 
all the disinfectants with only 16.0 % of the 
isolates susceptible to it. 
 
DISCUSSION 
This study summarizes the results of a two-year 
surveillance in the two selected states of Nigeria. 
Most of the health care facilities surveyed are 
tertiary care specialist hospitals, tertiary 
institutions in Ekiti and Ondo States, Nigeria. A 
total of 1,200 isolates of S. aureus from various 
non-repeat clinical samples was recovered in the 
participating hospitals and communities out of 
which 156 (13.0%) were identified as MRSA. This 
was below that of Onemu and Ophori40 that 
reported 79% resistance to methicillin among the 
clinical S. aureus isolates. This incidence of MRSA 
among the patients observed in this study was 
lower than the range between 24. % and 34.1 % 
recorded by Akujobi et al.5 among different cadres 
of healthcare workers in Nigeria. Onemu and 
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Akujobi et al.5 in Edo and Anambra States both in 
Nigeria. Fifty eight (37.2%), 23 (40.0%) and 98 
(62.8%) MRSA strains were isolated from 
apparently healthy volunteers, apparently healthy 
hospital personnel/health care workers (HCWs) 
and patients respectively. The high incidence of 
MRSA among patients could be due to reasons 
ranging from being acquired from hospital 
workers who introduced the organism into 
hospital environment (as nosocomial infection) 
from the community, abuse/misuse of antibiotics 
and low immunity in patients as a result of disease 
conditions17,7,25,40. This agrees with earlier reports 
by Abraham and collegues1. There was no 
statistically significant difference between the 
prevalence of MRSA and age or sex (p<0.05).  
The antibiotic sensitivity pattern of the isolates 
shows that ciprofloxacin was the most effective 
followed by ofloxacin, pefloxacin, gentamycin, 
erythromycin, augmentin, vancomycin, amoxycillin 
and cotrimoxazole in that order (Table 2). 
Statistically, there was no significant difference 
between the resistance to antibiotics among MRSA 
from healthy volunteers and patients (p < 
0.05).The result of this study reveals the efficacy of 
members of floroquinolones over the other 
antibiotics. The study shows that the likes of 
cotrimoxazole, amoxycillin, vancomycin, 
augmentin and erythromycin, to a high degree, 
were an unreliable empirical choice of antibiotics 
for the treatment of infections with MRSA strains 
as the aetiological agents17,46,49.   
Considering the general overview of the antibiotic 
susceptibility profile of the strains isolated in this 
study, the susceptibility of the MRSA strains to 
ciprofloxacin (98.7 %) may be due in part to it non-
availability and exorbitant cost unlike the 
commonly used antibiotics which are cheaper and 
could easily be afforded. The newer and expensive 
antibiotics have undoubtedly high antibacterial 
efficacy against MRSA in this study.  
The antibacterial activity of five commonly used 
biocides on the 156 MRSA strains showed the 
efficacy of the biocides used  Izal®, Morigad®, 
Septol®, Purit® and Dettol® in that order on MRSA 
strains isolated.  The finding in this study agrees 
with reports that resistance to benzalkonium 
chloride, a biocide, has been closely linked to 
oxacillin resistance in S. aureus33,24,16.  
It was reported that resistance to both biocides 
and antibiotics can be plasmid-mediated. Plasmid-
mediated resistance to biocides is a well-
recognized phenomenon. Such resistance to 
quaternary ammonium chlorides and other 
biocides has been identified in nosocomial 
pathogens51,14.  Resistance to antibiotics and 
biocides may be due to the common target site 
between the two antimicrobial agents which may 
bring about selection of mutants altered in such 
target by either agents or the emergence of cross-
resistance9,20,30. It has been suggested that subtle 
differences in the biocide susceptibility of 
antibiotic-resistant strains might facilitate their 
selection and maintenance in the environment by 
low-sub-effective concentrations of the 
agents34,35,41,15  owing to indiscriminate and on 
inappropriate use11,19,22,16,24,41. 
This study shows that there is a relatively high 
incidence of MRSA (13%) that are resistant to 
antibiotics and biocides in the study locations. A 
continuous surveillance is therefore recommended 
because of the public health importance of the 
organism and the high danger this may potent. 
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